227 related articles for article (PubMed ID: 10843192)
1. Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues.
Bidart JM; Mian C; Lazar V; Russo D; Filetti S; Caillou B; Schlumberger M
J Clin Endocrinol Metab; 2000 May; 85(5):2028-33. PubMed ID: 10843192
[TBL] [Abstract][Full Text] [Related]
2. Sodium iodide symporter and pendrin expression in human thyroid tissues.
Mian C; Lacroix L; Alzieu L; Nocera M; Talbot M; Bidart JM; Schlumberger M; Caillou B
Thyroid; 2001 Sep; 11(9):825-30. PubMed ID: 11575851
[TBL] [Abstract][Full Text] [Related]
3. Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues.
Porra V; Bernier-Valentin F; Trouttet-Masson S; Berger-Dutrieux N; Peix JL; Perrin A; Selmi-Ruby S; Rousset B
J Clin Endocrinol Metab; 2002 Apr; 87(4):1700-7. PubMed ID: 11932304
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome.
Taylor JP; Metcalfe RA; Watson PF; Weetman AP; Trembath RC
J Clin Endocrinol Metab; 2002 Apr; 87(4):1778-84. PubMed ID: 11932316
[TBL] [Abstract][Full Text] [Related]
5. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells.
Royaux IE; Suzuki K; Mori A; Katoh R; Everett LA; Kohn LD; Green ED
Endocrinology; 2000 Feb; 141(2):839-45. PubMed ID: 10650967
[TBL] [Abstract][Full Text] [Related]
6. Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells.
Bidart JM; Lacroix L; Evain-Brion D; Caillou B; Lazar V; Frydman R; Bellet D; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4367-72. PubMed ID: 11095481
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
[TBL] [Abstract][Full Text] [Related]
8. Genetics and phenomics of Pendred syndrome.
Bizhanova A; Kopp P
Mol Cell Endocrinol; 2010 Jun; 322(1-2):83-90. PubMed ID: 20298745
[TBL] [Abstract][Full Text] [Related]
9. The Pendred syndrome gene encodes a chloride-iodide transport protein.
Scott DA; Wang R; Kreman TM; Sheffield VC; Karniski LP
Nat Genet; 1999 Apr; 21(4):440-3. PubMed ID: 10192399
[TBL] [Abstract][Full Text] [Related]
10. Sulfate transport is not impaired in pendred syndrome thyrocytes.
Kraiem Z; Heinrich R; Sadeh O; Shiloni E; Nassir E; Hazani E; Glaser B
J Clin Endocrinol Metab; 1999 Jul; 84(7):2574-6. PubMed ID: 10404839
[TBL] [Abstract][Full Text] [Related]
11. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.
Lacroix L; Pourcher T; Magnon C; Bellon N; Talbot M; Intaraphairot T; Caillou B; Schlumberger M; Bidart JM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1423-8. PubMed ID: 15001644
[TBL] [Abstract][Full Text] [Related]
12. Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4).
Scott DA; Wang R; Kreman TM; Andrews M; McDonald JM; Bishop JR; Smith RJ; Karniski LP; Sheffield VC
Hum Mol Genet; 2000 Jul; 9(11):1709-15. PubMed ID: 10861298
[TBL] [Abstract][Full Text] [Related]
13. Pendred syndrome and iodide transport in the thyroid.
Kopp P; Pesce L; Solis-S JC
Trends Endocrinol Metab; 2008 Sep; 19(7):260-8. PubMed ID: 18692402
[TBL] [Abstract][Full Text] [Related]
14. Pendred syndrome.
Wémeau JL; Kopp P
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):213-224. PubMed ID: 28648509
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis between Pendred and pseudo-Pendred syndromes: clinical, radiologic, and molecular studies.
Fugazzola L; Cerutti N; Mannavola D; Crino A; Cassio A; Gasparoni P; Vannucchi G; Beck-Peccoz P
Pediatr Res; 2002 Apr; 51(4):479-84. PubMed ID: 11919333
[TBL] [Abstract][Full Text] [Related]
16. Expression of pendrin in benign and malignant human thyroid tissues.
Skubis-Zegadło J; Nikodemska A; Przytuła E; Mikula M; Bardadin K; Ostrowski J; Wenzel BE; Czarnocka B
Br J Cancer; 2005 Jul; 93(1):144-51. PubMed ID: 15942636
[TBL] [Abstract][Full Text] [Related]
17. Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues.
Caillou B; Dupuy C; Lacroix L; Nocera M; Talbot M; Ohayon R; Dème D; Bidart JM; Schlumberger M; Virion A
J Clin Endocrinol Metab; 2001 Jul; 86(7):3351-8. PubMed ID: 11443211
[TBL] [Abstract][Full Text] [Related]
18. The role of pendrin in iodide regulation.
Fugazzola L; Cerutti N; Mannavola D; Vannucchi G; Beck-Peccoz P
Exp Clin Endocrinol Diabetes; 2001; 109(1):18-22. PubMed ID: 11573133
[TBL] [Abstract][Full Text] [Related]
19. Pendred syndrome.
Glaser B
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():199-204; discussion 204. PubMed ID: 16444159
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]